Modeling and Therapeutic Targeting of p21-Activated Kinase Members in High-Risk Rhabdomyosarcoma |
Baylor College of Medicine / Jason Yustein, MD/PhD |
Innovation Grants |
2018 |
Texas |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Fatigue and Carnitine Levels over Eight Cycles of Chemotherapy in Children and Adolescents.
|
Baylor College of Medicine / Marilyn Hockenberry |
Nurse Researcher Grants |
2008 |
Texas |
Validation of microRNAs as valid targets in a pediatric sarcoma |
University of Texas Southwestern Medical Center / Mark Hatley |
Young Investigator Grants |
2011 |
Texas |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |
Immunotherapy for Osteosarcoma and Ewing sarcoma
|
Baylor College of Medicine / Nabil Ahmed, MD, MSc |
Young Investigator Grants |
2007 |
Texas |
Targeting PLK1 as a Common Mechanism in Ph-like ALL |
University of Texas M.D. Anderson Cancer Center / Joya Chandra, PhD |
Reach Grants |
2016 |
Texas |
Energy Balance Strategies for Decreasing Chemotherapy-Induced Cardiotoxicity |
University of Texas M.D. Anderson Cancer Center / Eugenie Kleinerman, MD |
Innovation Grants |
2018 |
Texas |
Combining Oncolytic Vaccinia Virus with GD2.CAR-modified Vaccinia Virus-specific T-cells for the Treatment of Relapsed Neuroblastoma and Sarcoma |
Baylor College of Medicine / Cliona Rooney, PhD |
Reach Grants |
2013 |
Texas |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |